[The relationship between Chlamydia pneumoniae and atherosclerosis].

Area of Science:

• Cardiovascular Medicine
• Infectious Diseases
• Pathology

Context:

• Atherosclerosis is a multifactorial disease with identified risk factors.
• The role of infectious agents, specifically Chlamydia pneumoniae, in atheromatous lesion development has been investigated.
• Ischemic cardiovascular diseases are a major global health concern.

Purpose:

• To evaluate the association between Chlamydia pneumoniae infection and the development of atherosclerosis.
• To review evidence from serological, histopathological, pathophysiological, and animal studies supporting this association.
• To assess the impact of antibiotic therapies on cardiovascular disease prevention.

Summary:

• Multiple study approaches, including serology and histopathology, indicate a link between Chlamydia pneumoniae and cardiovascular disease.
• Therapeutic trials using antibiotics like roxithromycin and azithromycin have shown efficacy in secondary prevention of ischemic heart disease.
• The biological plausibility of this association is supported, but further research is required.

Impact:

• Findings suggest Chlamydia pneumoniae as a potential contributing factor in atherosclerosis and ischemic heart disease.
• Antibiotic interventions may offer a novel strategy for secondary prevention of cardiovascular events.
• Future research should focus on improved diagnostics, pathogen viability in plaques, immune response, and primary prevention trials.